MedPAC examines Medicare quality measurement, drug spending
At this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Innovation Center Aug. 12 released an FAQ on the Wasteful and Inappropriate Service Reduction Model, a six-…
Headline
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier…
Headline
The Health Resources and Services Administration has awarded more than $15 million in grants to 58 rural health organizations for four-year projects as part of…
Headline
The American Organization for Nursing Leadership Aug, 15 announced that Stuart Downs, DNP, R.N., was elected as the 2026 president-elect of the AONL Board of…
Perspective
The job description for the ideal health care leader in coming years might read something like this:Wanted: Bold, compassionate innovator who unites clinical…
Headline
The Cybersecurity and Infrastructure Security Agency, Environmental Protection Agency, National Security Agency, FBI and international agencies Aug. 13…